ABSTRACT
Peroxisome proliferator-activated receptor-δ (PPARD) is upregulated in many major human cancers, but the role that its expression in cancer cells has in metastasis remains poorly understood. Here, we show that specific PPARD downregulation or genetic deletion of PPARD in cancer cells significantly repressed metastasis in various cancer models in vivo. Mechanistically, PPARD promoted angiogenesis via interleukin 8 in vivo and in vitro. Analysis of transcriptome profiling of HCT116 colon cancer cells with or without genetic deletion of PPARD and gene expression patterns in The Cancer Genome Atlas colorectal adenocarcinoma database identified novel pro-metastatic genes (GJA1, VIM, SPARC, STC1, SNCG) as PPARD targets. PPARD expression in cancer cells drastically affected epithelial-mesenchymal transition, migration, and invasion, further underscoring its necessity for metastasis. Clinically, high PPARD expression in various major human cancers (e.g., colorectal, lung, breast) was associated with significantly reduced metastasis-free survival. Our results demonstrate that PPARD, a druggable protein, is an important molecular target in metastatic cancer.
Subject(s)
Gene Expression Profiling/methods , Lung Neoplasms/genetics , Neoplasm Metastasis/genetics , Neoplasms/genetics , PPAR delta/genetics , Angiogenesis Inducing Agents/metabolism , Animals , Down-Regulation/genetics , Epithelial-Mesenchymal Transition/genetics , Female , Gene Deletion , Gene Expression , Gene Expression Regulation, Neoplastic , HCT116 Cells/cytology , HCT116 Cells/metabolism , Humans , Interleukin-8/metabolism , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Mice , Molecular Targeted Therapy/methods , Neoplasm Metastasis/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , PPAR delta/metabolismABSTRACT
Depletion of microtubule (MT) regulators can initiate stable alterations in MT assembly rates that affect chromosome instability and mitotic spindle function, but the manner by which cellular MT assembly rates can stably increase or decrease is not understood. To investigate this phenomenon, we measured the response of microtubule assembly to both rapid and long-term loss of MT regulators MCAK/Kif2C and Kif18A. Depletion of MCAK/Kif2C by siRNA stably decreases MT assembly rates in mitotic spindles, whereas depletion of Kif18A stably increases rates of assembly. Surprisingly, this is not phenocopied by rapid rapamycin-dependent relocalization of MCAK/Kif2C and Kif18A to the plasma membrane. Instead, this treatment yields opposite affects on MT assembly. Rapidly increased MT assembly rates are balanced by a decrease in nucleated microtubules, whereas nucleation appears to be maximal and limiting for decreased MT assembly rates and also for long-term treatments. We measured amplified tubulin synthesis during long-term depletion of MT regulators and hypothesize that this is the basis for different phenotypes arising from long-term versus rapid depletion of MT regulators.
Subject(s)
Kinesins/metabolism , Microtubules/metabolism , Cell Membrane/metabolism , HCT116 Cells/cytology , HCT116 Cells/drug effects , HeLa Cells/cytology , HeLa Cells/drug effects , Humans , Kinesins/genetics , Microtubule-Associated Proteins/metabolism , Microtubules/drug effects , Microtubules/genetics , RNA, Small Interfering , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sirolimus/pharmacology , Spindle Apparatus/metabolism , Tacrolimus Binding Proteins/genetics , Tacrolimus Binding Proteins/metabolismABSTRACT
Neovascularization drives tumor development, and angiogenic factors are important neovascularization initiators. We recently identified the secreted angiogenic factor CNPY2, but its involvement in cancer has not been explored. Herein, we investigate CNPY2's role in human colorectal cancer (CRC) development. Tumor samples were obtained from CRC patients undergoing surgery. Canopy 2 (CNPY2) expression was analyzed in tumor and adjacent normal tissue. Stable lines of human HCT116 cells expressing CNPY2 shRNA or control shRNA were established. To determine CNPY2's effects on tumor xenografts in vivo, human CNPY2 shRNA HCT116 cells and controls were injected into nude mice, separately. Cellular apoptosis, growth, and angiogenesis in the xenografts were evaluated. CNPY2 expression was significantly higher in CRC tissues. CNPY2 knockdown in HCT116 cells inhibited growth and migration and promoted apoptosis. In xenografts, CNPY2 knockdown prevented tumor growth and angiogenesis and promoted apoptosis. Knockdown of CNPY2 in the HCT116 CRC cell line reversibly increased p53 activity. The p53 activation increased cyclin-dependent kinase inhibitor p21 and decreased cyclin-dependent kinase 2, thereby inhibiting tumor cell growth, inducing cell apoptosis, and reducing angiogenesis both in vitro and in vivo. CNPY2 may play a critical role in CRC development by enhancing cell proliferation, migration, and angiogenesis and by inhibiting apoptosis through negative regulation of the p53 pathway. Therefore, CNPY2 may represent a novel CRC therapeutic target and prognostic indicator.
Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/metabolism , Gene Expression Regulation, Neoplastic/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adult , Aged , Aged, 80 and over , Animals , Apoptosis/drug effects , Cell Proliferation/drug effects , Colorectal Neoplasms/genetics , Female , HCT116 Cells/cytology , Humans , Intracellular Signaling Peptides and Proteins/genetics , Male , Membrane Proteins/genetics , Mice, Nude , Middle Aged , Neovascularization, Pathologic/genetics , Prognosis , Tumor Suppressor Protein p53/metabolism , Xenograft Model Antitumor Assays/methodsABSTRACT
Rational development of more physiologic in vitro models includes the design of robust and flexible 3D-microtissue-based multi-tissue devices, which allow for tissue-tissue interactions. The developed device consists of multiple microchambers interconnected by microchannels. Pre-formed spherical microtissues are loaded into the microchambers and cultured under continuous perfusion. Gravity-driven flow is generated from on-chip reservoirs through automated chip-tilting without any need for additional tubing and external pumps. This tilting concept allows for operating up to 48 devices in parallel in order to test various drug concentrations with a sufficient number of replicates. For a proof of concept, rat liver and colorectal tumor microtissues were interconnected on the chip and cultured during 8 days in the presence of the pro-drug cyclophosphamide. Cyclophosphamide has a significant impact on tumor growth but only after bio-activation by the liver. This effect was only observed in the perfused and interconnected co-cultures of different microtissue types on-chip, whereas the discontinuous transfer of supernatant via pipetting from static liver microtissues that have been treated with cyclophosphamide did not significantly affect tumor growth. The results indicate the utility and multi-tissue functionality of this platform. The importance of continuous medium circulation and tissue interaction is highlighted.
Subject(s)
Coculture Techniques/methods , Liver/cytology , Microfluidic Analytical Techniques/instrumentation , Spheroids, Cellular/cytology , Tissue Culture Techniques/methods , Animals , Antineoplastic Agents, Alkylating/pharmacology , Cell Survival/drug effects , Cells, Cultured , Coculture Techniques/instrumentation , Cyclophosphamide/pharmacology , HCT116 Cells/cytology , HCT116 Cells/drug effects , Humans , Microfluidic Analytical Techniques/methods , Rats , Spheroids, Cellular/drug effects , Tissue Culture Techniques/instrumentationABSTRACT
The objective of the present study was to investigate cloning, expression, and functions of the recombinant protein, Siva1. Siva1 gene was synthesized by RT-PCR from HCT116 cells. Plasmids were cleaved with the restriction endonuclease, BamH1/Sal1 and products were connected to pQE30, which underwent cleavage by BamH1/Sal1. The recombinant plasmid, pQE30-Siva1, was identified after digestion with restriction endonucleases followed by transformation into E. coli M15. Expression of Siva1 was induced by IPTG and identified by SDS- PAGE following purification with affinity chromatography. The results showed that size of Siva1 was 12 kDa, consistent with the molecular weight of the His-Siva1 fusion protein. Functional test demonstrated that Siva1 significantly inhibited the invasion and migration of HCT116 cells. It may thus find clinical application for control of cancers.
Subject(s)
Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/isolation & purification , Cloning, Molecular/methods , Gene Expression Regulation, Neoplastic , Cell Movement/genetics , Colorectal Neoplasms/genetics , Colorectal Neoplasms/physiopathology , Electrophoresis, Polyacrylamide Gel/methods , Escherichia coli/genetics , Genetic Engineering/methods , HCT116 Cells/cytology , HCT116 Cells/physiology , Humans , Plasmids/genetics , Real-Time Polymerase Chain Reaction/methods , Recombinant Fusion Proteins/genetics , Sensitivity and Specificity , Tumor Cells, CulturedABSTRACT
Cell-in-cell structures represent live cell events in which one cell internalizes another. Because formation of cell-in-cell structures is a rare event in most cell types and the event is associated with cell death, there has been limited clarification of this phenomenon, and its physiological role and molecular mechanism are yet to be precisely elucidated. In this study, we established a mutagenized cell line that exhibited cell-in-cell structures at a more than 10-fold higher frequency as compared to the parent cells. Interestingly, both engulfment and invasion were increased in the mutagenized cell line as compared with that in the parent cell line in the suspension culture condition. This finding indicates that this mutagenized cell line showed an interchangeable status in terms of its ability to form cell-in-cell structures, and the system described here could be useful for elucidation of the mechanisms regulating the formation of cell-in-cell structures, including engulfment and invasion, in a given cellular environment. Further studies using this cell line are warranted to understand the mechanism of formation and biological significance of the cell-in-cell formation.
Subject(s)
Cell-in-Cell Formation , HCT116 Cells/cytology , Aminacrine/analogs & derivatives , Aminacrine/pharmacology , HCT116 Cells/metabolism , Humans , Mutagenesis , Mutation Rate , Nitrogen Mustard Compounds/pharmacology , PhenotypeABSTRACT
Activation of the PI3K/Akt pathway is associated with tumorigenesis and resistance to apoptosis and ionizing radiation (IR). We sought to characterize the effects of physiologic and genetic manipulation of Akt signaling on IR-induced gastrointestinal (GI) apoptosis in mice. PI3K/Akt signaling is stimulated by insulin. We evaluated the time course of Akt stimulation by insulin and found it overlapped with protection from apoptosis induced by TRAIL (TNFalpha Related Apoptosis Inducing Ligand) in cell lines. Mice were treated with insulin and glucose and the kinetics of in vivo Akt stimulation were determined by phospho-Akt (S473) (P-Akt) immunofluorescence in the gut. Irradiation of mice by five Gy at 30 minutes after insulin/glucose administration induced apoptosis in the crypts of the ileum and colon after six hours, but induced little apoptosis in the liver or esophagus. Pre-treatment with insulin and glucose did not significantly alter levels of IR-induced apoptosis in the gut. IR alone led to sustained increases in P-Akt in the gut at six hours, a protective response that may have precluded additional protection from insulin/glucose. In Akt1-/- mice, there was significantly more apoptosis in ileum crypts of irradiated mice compared to Akt1+/+ mice, suggesting a role for the pathway in the GI tract in response to IR. Taken together, modulation of the PI3K/Akt pathway may sensitize or protect against cancer therapies in both tumor and normal tissues.